Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Apffelstaedt, J. P.
Right arrow Articles by Karakousis, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Apffelstaedt, J. P.
Right arrow Articles by Karakousis, C. P.

Annals of Surgical Oncology, Vol 3, Issue 3 304-309, Copyright © 1996 by Society of Surgical Oncology

ARTICLES

Complications and outcome of external hemipelvectomy in the management of pelvic tumors

J. P. Apffelstaedt, D. L. Driscoll, J. E. Spellman, A. F. Velez, J. F. Gibbs and C. P. Karakousis
Roswell Park Cancer Institute, Buffalo, New York, USA.

BACKGROUND: Although the technique of external hemipelvectomy has been adequately described, little is known about its complications and late results. DESIGN: Retrospective review of 68 external hemipelvectomies performed at our Institute between 1973 and 1994. MATERIALS AND METHODS: Eleven patients had bone tumor; 39 patients, soft-tissue sarcoma; seven patients, melanoma; 10 patients, squamous cell carcinoma; and one patient, giant neurofibroma. In 48 (71%) patients, the intent was curative. In 17 cases, the hemipelvectomy was extended. RESULTS: Postoperative complications occurred in 36 (53%) patients, including flap necrosis in 11 (16%), wound infection in 24 (35%), and other complications in 12 (18%). Four (6%) patients died postoperatively. The average hospital stay after curative versus palliative resection was 39 versus 24 days. Only three (5%) patients were able to use a prosthesis, whereas 55 (81%) used crutches, six (9%) remained wheelchair bound, and four patients (6%) spent most of the time in bed. Local recurrence occurred in 35% of the patients. The estimated 5-year survival for curatively resected patients was 21%. CONCLUSIONS: External hemipelvectomy is a procedure with considerable morbidity and is indicated for only a minority of far-advanced tumors. It offers a chance of palliation and possibly cure when lesser surgical options have been exhausted.


This article has been cited by other articles:


Home page
 ptjournalHome page
L. A Beck, M. J Einertson, M. H Winemiller, R. W DePompolo, K. M Hoppe, and F. F Sim
Functional Outcomes and Quality of Life After Tumor-Related Hemipelvectomy
Physical Therapy, August 1, 2008; 88(8): 916 - 927.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. Senchenkov, S. L. Moran, P. M. Petty, J. Knoetgen III, R. P. Clay, U. Bite, S. A. Barnes, and F. H. Sim
Predictors of Complications and Outcomes of External Hemipelvectomy Wounds: Account of 160 Consecutive Cases
Ann. Surg. Oncol., January 1, 2008; 15(1): 355 - 363.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. N. Kulaylat, A. Froix, and C. P. Karakousis
Blood Supply of Hemipelvectomy Flaps: The Anterior Flap Hemipelvectomy
Arch Surg, July 1, 2001; 136(7): 828 - 831.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Society of Surgical Oncology.